JMIR Publications has announced the appointment of Dr. Syed AA Rizvi as the new Editor-in-Chief of JMIR Biomedical Engineering, effective immediately.
Dr. Rizvi, a distinguished professor of pharmaceutical and biomedical sciences, brings a wealth of expertise to his new role. With a strong passion for advancing medical innovation and over 26 years of experience in industrial, academic, and healthcare settings, Dr. Rizvi is uniquely positioned to lead JMIR Biomedical Engineering into a new era of growth and impact.
Highly motivated and committed to medical innovation and education, Dr. Rizvi has a remarkable track record of discovering new therapies, improving patient outcomes, and contributing to scientific and business strategies. His extensive body of work includes over 250 peer-reviewed publications, which have been cited more than 5,200 times. Dr. Rizvi has also contributed to prestigious journals, books, and US patents, and presented at numerous conferences.
In addition to his research contributions, Dr. Rizvi serves on the editorial boards of various scientific journals and has reviewed manuscripts and books for over 200 publications. His research interests span a wide range of fields, including clinical trials, pharmaceutical formulations, nano- and micro-encapsulation of drugs, biotechnology, and the development of digital tools for healthcare.
JMIR Biomedical Engineering, established in 2016, is a leading platform for original research, viewpoints, and reviews in the field of biomedical engineering. Dr. Rizvi’s appointment aligns perfectly with the journal’s mission to publish high-quality, impactful open access research. His dedication to fostering the next generation of biomedical engineers will further enhance the journal’s commitment to excellence.
Click here to read the original press release.
